US Congressional Research Service Report on Pharmaceutical Supply Chain Security
The Congressional Research Service (CRS) prepares reports for the Members and Committees of the US Congress. On 12 July 2013 they published a report titled “Pharmaceutical Supply Chain Security” that addressed the complexities in the global distribution supply chain for finished drug products.
The complexities are well illustrated and described in Figure 1 (page 6) and a textbox (page 5) respectively. Between the time when a finished drug leaves the manufacturer it may pass through multiple primary and secondary wholesale distributors and often multiple dispensers before actually reaching the patient. This supply chain may also include a re-packager and third party logistics providers including temporary transport companies or warehouse providers. The complexity of the supply chain provides multiple opportunities for adulteration, drug diversion and counterfeiting. This report describes how Congress has moved to regulate the supply chain with details on the following:
• Prescription Drug Marketing Act of 1987
• Amendments to the Food and Drug Act in 2007
• Food and Drug Administration Safety and Innovation Act of 2012
• State Activities on Supply Chain Security
• Actions taken by Professional and Industry Associations
• Policy Decision Points under Consideration in the 113th Congress
To view or download the Congressional Research Service Report, click here
To view or download the Rx-360 Summary of the Report, click here
Related News
-
News Pharmaceutical industry supports COP28 health stance in joint statement
As COP28 takes place over this week in Dubai, UAE, several bodies in the pharmaceutical and health industries have come together to announce support of key movements in sustainability in the sector, and to recognise sustainability as a health issue.&nb... -
News Biden backs Cold-War measures to shore-up medical supply chains
In a recent strategy to combat rising inflation and the cost of living crisis, President Joe Biden has invoked a Cold War-era act to increase investment in a selection of medicines and supplies. -
News CPHI Podcast Series: What does the changing US Pharma market mean for industry and patients alike?
In this week's episode of the CPHI Podcast Series Lucy Chard, Digital Editor for CPHI Online is joined by James Manser to discuss the political and market changes in the US pharma field. -
News Which 10 drugs are open to price negotiation with Medicare in the USA?
The Centres for Medicare & Medicaid Services, under the Biden administration in the USA, has released a list of the 10 drugs that will be open to price negotiations as part of the new legislation under the Inflation Reduction Act (IRA). -
News 10 Major Drug Approvals So Far in 2023
Last year, 37 novel drugs were approved by the FDA, this was a high number for such a category, and covered many fields including oncology, demonstrating how promising further research is, and how it is only continuing to build. To date, there are alre... -
News Novartis agrees for copies to be made of cancer drug to reach poorer countries
Novartis signs agreement with MPP to have generics of it's leukemia drug made so that it can be more easily distributed to the world's poorer countries. -
News CPHI Podcast Series: outsourcing and manufacturing trends
Listen to the CPHI Podcast Series this June to hear Gil Roth of the PBOA speak with Digital Editor Lucy Chard about the biggest trends and topics to watch in pharma outsourcing and manufacturing at the minute. -
News New WHO health emergency guidelines expect full transparency from Big Pharma
The WHO are proposing a new set of pandemic guidelines to set out how future global health crises should be handled.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance